Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.33 |
| ▸ | EGFR | P00533 | 3/20 | 0.32 |
| ▸ | LATS1 | O95835 | 1/20 | 0.31 |
| ▸ | LATS2 | Q9NRM7 | 1/20 | 0.31 |
| ▸ | OGA | O60502 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26423732 | 0.88 | LATS1 (0.33) | CYP2A6EGFRLATS1LATS2 | |
| SCHEMBL26423745 | 0.79 | EGFR (0.33) | CYP2A6EGFRLATS1LATS2OGA | |
| SCHEMBL26423740 | 0.79 | CYP2A6 (0.36) | CYP2A6 | |
| SCHEMBL26423713 | 0.78 | CYP2A6 (0.33) | CYP2A6OGA | |
| SCHEMBL26423675 | 0.78 | EGFR (0.39) | CYP2A6EGFRLATS1LATS2 | |
| SCHEMBL24270404 | 0.77 | CYP2A6 (0.34) | CYP2A6EGFR | |
| SCHEMBL26423725 | 0.77 | KDM4E (0.36) | EGFR | |
| SCHEMBL26423730 | 0.77 | LIMK1 (0.36) | CYP2A6EGFR | |
| SCHEMBL26423604 | 0.76 | ALDH1A1 (0.38) | CYP2A6 | |
| SCHEMBL26423660 | 0.75 | EGFR (0.39) | CYP2A6EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | OCIAD2, OCIAD1, AZI2 | CYP2A6 1228/4885EGFR 1270/4885LATS1 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.